Patents Examined by K. S. McCowin
  • Patent number: 4976957
    Abstract: Disclosed herein are a novel group of compounds, termed Recognins, and particularly Recognin M and Recognin L produced, respectively, from artificial mammary and lymphoma cancer cells. The Recognins are useful for diagnostic purposes.
    Type: Grant
    Filed: July 9, 1981
    Date of Patent: December 11, 1990
    Inventor: Samuel Bogoch
  • Patent number: 4505756
    Abstract: A maltodextrin phosphorylase limit dextrin in the presence of maltodextrin phosphorylase and inorganic phosphate, is used as a substrate for alpha-amylase, which initiates a series of enzymatic reactions resulting in a chromogen response which can be used to measure the concentration of alpha-amylase in a body fluid. A novel limit dextrin and its preparation also are described.
    Type: Grant
    Filed: September 1, 1981
    Date of Patent: March 19, 1985
    Assignee: CooperBiomedical, Inc.
    Inventors: Paul T. Nix, Rebecca D. Goldfarb, Linda J. Stong, Lorraine E. Sulick, Ramesh C. Trivedi, Stanley W. Morgenstern
  • Patent number: 4503155
    Abstract: The present invention discloses multifunctional recombinant DNA cloning vectors for use in Streptomyces, Bacillus, and E. coli. The invention further discloses transformants of the aforementioned vectors.
    Type: Grant
    Filed: February 1, 1982
    Date of Patent: March 5, 1985
    Assignee: Eli Lilly and Company
    Inventors: James R. Miller, Jeffrey T. Fayerman, Steven Kovacevic, Nancy E. Beerman
  • Patent number: 4500509
    Abstract: Differentiation, identification and enumeration of dye responsive human blood cells essential to diagnosis and prognosis of certain diseases is established by preparation of the reaction product of a human blood specimen of the patient in an aqueous fixative-free environment at blood temperatures with selected basic, cationic quaternary dyes, particularly basic orange #21. The so-prepared specimen becomes instantly responsive to emissive wave energy source exposure to stimulate reproducible fluorescent light emission from all of said dye responsive cells. The quantum of said fluorescent light energy emitted provides individual sets of data response relative to hue, value, chroma and intensity to permit differentiation, identification and enumeration of all of said dye responsive components in said blood specimen. By use of a bi-modal wave energy system involving additional use of white light wave energy absorbance, independent sets of data can provide both confirmatory and ancillary information.
    Type: Grant
    Filed: March 9, 1982
    Date of Patent: February 19, 1985
    Inventor: Lawrence Kass
  • Patent number: 4493821
    Abstract: A fixative composition for histological, cytological, immunological and proteinaceous preparations comprising a mixture of pyrrolid-2-one, a polyol, a urea and a zinc salt of a non-oxidizing organic or inorganic acid. Also disclosed are devices utilizing such compositions.
    Type: Grant
    Filed: February 4, 1982
    Date of Patent: January 15, 1985
    Inventor: James S. Harrison
  • Patent number: 4493893
    Abstract: An improved process for producing a thermostable alpha-amylase enzyme is described. The gene coding for the alpha-amylase is incorporated into a chimeric plasmid which is produced in multiple copies by a host microorganism.
    Type: Grant
    Filed: March 11, 1983
    Date of Patent: January 15, 1985
    Assignee: CPC International Inc.
    Inventors: Jonathan R. Mielenz, Susan Mickel
  • Patent number: 4480036
    Abstract: The invention relates to an extremely thermophilic bacterium, Thermus T-351, and a thermophilic protease, Caldolysin, derived therefrom. The bacterium cells are Gram negative, non-sporulating rods. Its natural environment is a hot pool at 79.degree..+-.4.degree. C. The protease is stable at temperatures up to 75.degree. C. at a pH range of 4 to 12. It is most active at temperatures of 65.degree. C. to 85.degree. C. but retains at least some activity at lower temperatures.
    Type: Grant
    Filed: August 8, 1980
    Date of Patent: October 30, 1984
    Assignee: Development Finance Corporation
    Inventors: Hugh W. Morgan, Roy M. Daniel, Donald A. Cowan, Christopher W. Hickey
  • Patent number: 4476230
    Abstract: A process for the detection and for the determination of immunocomplexes in liquids is described. It is based on determining the rate at which the immunoglobulin or the antigen present in the complex reacts with an appropriate immuno-partner, and relating this rate to the rate at which this immunoglobulin or antigen reacts with the corresponding immuno-partner in an immunocomplex-free liquid.
    Type: Grant
    Filed: February 12, 1981
    Date of Patent: October 9, 1984
    Assignee: Behringwerke Aktiengesellschaft
    Inventor: Axel Sieber
  • Patent number: 4469791
    Abstract: Genetically engineered microorganisms are provided which contain recombinant DNA with an amylase coding gene. Improved yields of amylase enzymes are obtained by cultivating these microorganisms.
    Type: Grant
    Filed: February 13, 1981
    Date of Patent: September 4, 1984
    Assignee: CPC International Inc.
    Inventors: Charles A. Colson, Pierre E. Cornelis, Colette S. Digneffe, Corinne Walon